文献速递疼痛医学

白杨素通过5-HT1A受体减轻小鼠神经病理性疼痛

5-HT1A receptor-mediated attenuation of heat hyperalgesia and mechanical allodynia by chrysin in mice with experimental mononeuropathy.
PubMed 文献 · Reg Anesth Pain Med · 2020-06-18

该研究在小鼠坐骨神经慢性压迫模型中发现,白杨素(3-30 mg/kg,口服,每日两次,持续2周)剂量依赖性地改善热痛觉过敏和机械性异常性疼痛。其镇痛作用依赖5-HT系统,并被5-HT1A受体拮抗剂逆转,且可改善疼痛相关抑郁焦虑行为而不引起高血压危象。

要点

  • 白杨素剂量依赖性地减轻神经病理性疼痛行为。
  • 镇痛作用依赖5-HT系统及脊髓5-HT1A受体。
  • 白杨素可改善疼痛伴发的抑郁焦虑且无奶酪反应。

核心结论

  • 白杨素具有抗痛觉过敏和抗异常性疼痛效力,脊髓5-HT1A受体是关键机制。

研究设计与样本

  • 小鼠坐骨神经慢性压迫(CCI)模型,采用von Frey和Hargreaves测试评估疼痛行为。
  • 通过PCPA耗竭5-HT及体内外拮抗剂实验探讨5-HT相关机制。

主要发现

  • 白杨素(3-30 mg/kg,口服,每日两次,2周)剂量依赖性地改善热痛觉过敏和机械性异常性疼痛。
  • PCPA耗竭5-HT可 abolished 白杨素的镇痛作用,而5-羟色氨酸可增强其作用。
  • 白杨素提高脊髓单胺(尤其5-HT)水平并降低单胺氧化酶活性。
  • 5-HT1A受体拮抗剂WAY-100635(全身或脊髓给药)优先逆转白杨素的镇痛作用。
  • 体外白杨素(0.1-10 nM)增加5-HT1A激动剂8-OH-DPAT的最大效应(Emax)。

关键数值与推荐

  • 白杨素口服剂量3-30 mg/kg,每日两次,持续2周。
  • 体外白杨素浓度0.1-10 nM。

临床怎么用

  • 白杨素可能成为神经病理性疼痛的潜在治疗选择,其作用依赖于5-HT1A受体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent neuropathic pain poses a health problem, for which effective therapy or antidote is in dire need. This work aimed to investigate the pain-relieving effect of chrysin, a natural flavonoid with monoamine oxidase inhibitory activity, in an experimental model of neuropathic pain and elucidate mechanism(s). METHODS: Chronic constriction injury (CCI) was produced by loose ligation of sciatic nerve in mice. The pain-related behaviors were examined using von Frey test and Hargreaves test. The serotonin-related mechanisms were investigated by serotonin depletion with p-chlorophenylalanine (PCPA) and antagonist tests in vivo and in vitro. RESULTS: Repeated treatment of CCI mice with chrysin (orally, two times per day for 2 weeks) ameliorated heat hyperalgesia and mechanical allodynia in a dose-dependent fashion (3-30 mg/kg). The chrysin-triggered pain relief seems serotonergically dependent, since its antihyperalgesic and antiallodynic actions were abolished by chemical depletion of serotonin by PCPA, whereas potentiated by 5-hydroxytryptophan (a precursor of 5-HT). Consistently, chrysin-treated neuropathic mice showed enhanced levels of spinal monoamines especially 5-HT, with depressed monoamine oxidase activity. Moreover, chrysin-evoked pain relief was preferentially counteracted by 5-HT1A receptor antagonist WAY-100635 delivered systematically or spinally. In vitro, chrysin (0.1-10 nM) increased the maximum effect (Emax, shown as stimulation of [35S] GTPγS binding) of 8-OH-DPAT, a 5-HT1A agonist. Beneficially, chrysin was able to correct comorbid behavioral symptoms of depression and anxiety evoked by neuropathic pain, without causing hypertensive crisis (known as 'cheese reaction'). CONCLUSION: These findings confirm the antihyperalgesic and antiallodynic efficacies of chrysin, with spinal 5-HT1A receptors being critically engaged.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Wu J, Wang Y, Cui W, et al. 5-HT1A receptor-mediated attenuation of heat hyperalgesia and mechanical allodynia by chrysin in mice with experimental mononeuropathy. Reg Anesth Pain Med. 2020. PMID: 32561651. doi:10.1136/rapm-2020-101472

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。